STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ANIK ANIKA THERAPEUTICS INCORPORATED StockScouter® Report
4
StockScouter® Score
ANIKA THERAPEUTICS INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits meaningful strength. Postive
- One or more less experienced analysts has modestly increased quarterly earnings estimates for ANIK. Positive/Neutral
Concerns
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- The multi-period measure of relative price change and consistency is average. Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
D
C
C
C